Go Pro
→ Someone just dumped the biggest gold fund. (From Behind the Markets) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
DexCom, Inc. stock logo
DXCM
DexCom
$89.16
-2.1%		$78.15
$54.11
▼
$92.59
$34.36B1.415.74 million shs4.11 million shs
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$73.91
-0.4%		$67.01
$58.75
▼
$89.77
$33.51B0.694.10 million shs2.01 million shs
Globus Medical, Inc. stock logo
GMED
Globus Medical
$83.13
-1.1%		$80.82
$54.15
▼
$101.40
$11.29B0.951.39 million shs1.02 million shs
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$550.01
-1.7%		$559.34
$518.55
▼
$769.98
$44.08B1.54640,098 shs385,722 shs
Don't Wait for the OpenAI IPO Cover
Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
DexCom, Inc. stock logo
DXCM
DexCom
-2.09%-0.49%+24.63%+26.90%+17.38%
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
-0.38%+1.76%+22.00%+15.70%-0.91%
Globus Medical, Inc. stock logo
GMED
Globus Medical
-1.17%-4.13%+8.73%+0.65%+35.34%
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
-1.70%-0.60%+1.05%-0.18%-14.24%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
DexCom, Inc. stock logo
DXCM
DexCom
$89.16
-2.1%		$78.15
$54.11
▼
$92.59
$34.36B1.415.74 million shs4.11 million shs
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$73.91
-0.4%		$67.01
$58.75
▼
$89.77
$33.51B0.694.10 million shs2.01 million shs
Globus Medical, Inc. stock logo
GMED
Globus Medical
$83.13
-1.1%		$80.82
$54.15
▼
$101.40
$11.29B0.951.39 million shs1.02 million shs
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$550.01
-1.7%		$559.34
$518.55
▼
$769.98
$44.08B1.54640,098 shs385,722 shs
Don't Wait for the OpenAI IPO Cover
Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
DexCom, Inc. stock logo
DXCM
DexCom
-2.09%-0.49%+24.63%+26.90%+17.38%
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
-0.38%+1.76%+22.00%+15.70%-0.91%
Globus Medical, Inc. stock logo
GMED
Globus Medical
-1.17%-4.13%+8.73%+0.65%+35.34%
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
-1.70%-0.60%+1.05%-0.18%-14.24%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
DexCom, Inc. stock logo
DXCM
DexCom
2.89
Moderate Buy$88.71-0.51% Downside
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
2.48
Hold$77.735.16% Upside
Globus Medical, Inc. stock logo
GMED
Globus Medical
2.88
Moderate Buy$101.7722.42% Upside
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
2.60
Moderate Buy$747.0035.82% Upside

Current Analyst Ratings Breakdown

Latest GMED, IDXX, DXCM, and GEHC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/19/2026
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$79.00
8/12/2026
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C-)
8/11/2026
DexCom, Inc. stock logo
DXCM
DexCom
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold (C-) ➝ Hold (C)
8/11/2026
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
Barclays PLC logo
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOverweight$800.00 ➝ $710.00
8/11/2026
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong Sell ➝ Hold
8/10/2026
Globus Medical, Inc. stock logo
GMED
Globus Medical
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
8/7/2026
Globus Medical, Inc. stock logo
GMED
Globus Medical
Wells Fargo & Company logo
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOverweight$103.00 ➝ $99.00
8/5/2026
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$650.00 ➝ $670.00
8/5/2026
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$620.00 ➝ $670.00
8/4/2026
DexCom, Inc. stock logo
DXCM
DexCom
Argus logo
Argus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$86.00 ➝ $96.00
8/3/2026
DexCom, Inc. stock logo
DXCM
DexCom
Canaccord Genuity Group Inc. logo
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price TargetBuy$82.00 ➝ $90.00
(Data available from 8/26/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
DexCom, Inc. stock logo
DXCM
DexCom
$4.66B7.22$2.71 per share32.89$6.95 per share12.83
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$20.63B1.62$5.85 per share12.63$24.33 per share3.04
Globus Medical, Inc. stock logo
GMED
Globus Medical
$2.94B3.80$6.21 per share13.38$35.52 per share2.34
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$4.30B10.07$14.83 per share37.09$20.47 per share26.87
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
DexCom, Inc. stock logo
DXCM
DexCom
$836.30M$2.5335.2428.951.5420.12%35.94%14.75%10/29/2026 (Estimated)
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$2.08B$4.3616.9513.662.149.33%20.12%5.74%11/4/2026 (Estimated)
Globus Medical, Inc. stock logo
GMED
Globus Medical
$537.87M$3.9121.2615.661.3517.02%14.57%12.62%11/5/2026 (Estimated)
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$1.06B$14.2238.6833.092.9925.03%71.96%33.60%11/2/2026 (Estimated)

Latest GMED, IDXX, DXCM, and GEHC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2026Q2 2026
Globus Medical, Inc. stock logo
GMED
Globus Medical
$1.10$1.34+$0.24$1.10$782.88 million$789.61 million
8/4/2026Q2 2026
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
$3.94$4.27+$0.33$4.27$1.20 billion$1.22 billion
7/30/2026Q2 2026
DexCom, Inc. stock logo
DXCM
DexCom
$0.6110$0.70+$0.0890$0.64$1.29 billion$1.31 billion
7/29/2026Q2 2026
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$1.04$1.13+$0.09$1.24$5.26 billion$5.30 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
DexCom, Inc. stock logo
DXCM
DexCom
N/AN/AN/AN/AN/A
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$0.140.19%N/A3.21%1 Years
Globus Medical, Inc. stock logo
GMED
Globus Medical
N/AN/AN/AN/AN/A
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
N/AN/AN/AN/AN/A

Latest GMED, IDXX, DXCM, and GEHC Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/30/2026
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
quarterly$0.03500.23%7/24/20267/24/20268/14/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
DexCom, Inc. stock logo
DXCM
DexCom
0.47
1.73
1.43
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
0.92
1.26
0.97
Globus Medical, Inc. stock logo
GMED
Globus Medical
N/A
4.62
2.93
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
0.19
1.17
0.87

Institutional Ownership

CompanyInstitutional Ownership
DexCom, Inc. stock logo
DXCM
DexCom
97.75%
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
82.06%
Globus Medical, Inc. stock logo
GMED
Globus Medical
95.16%
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
87.84%

Insider Ownership

CompanyInsider Ownership
DexCom, Inc. stock logo
DXCM
DexCom
0.28%
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
0.36%
Globus Medical, Inc. stock logo
GMED
Globus Medical
18.38%
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
0.79%
CompanyEmployeesShares OutstandingFree FloatOptionable
DexCom, Inc. stock logo
DXCM
DexCom
11,000377.36 million376.30 millionOptionable
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
54,000451.69 million450.06 millionOptionable
Globus Medical, Inc. stock logo
GMED
Globus Medical
6,000134.26 million109.59 millionOptionable
IDEXX Laboratories, Inc. stock logo
IDXX
IDEXX Laboratories
11,00078.78 million78.16 millionOptionable

Recent News About These Companies

Here's Why Idexx Laboratories (IDXX) is a Strong Momentum Stock
August 24 at 10:51 AM  |  zacks.comhttps://www.zacks.com/stock/news/2978976/here-s-why-idexx-laboratories-idxx-is-a-strong-momentum-stock?cid=cs-stocknewsapi-ft-fundamental_analysis|zacks_education_momentum_score-2978976
5,245 Shares in IDEXX Laboratories, Inc. $IDXX Bought by Barbara Oil Co.
August 24 at 3:35 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-5245-shares-in-idexx-laboratories-inc-idxx-bought-by-barbara-oil-co-2026-08-24/
Great Lakes Advisors LLC Takes $2.10 Million Position in IDEXX Laboratories, Inc. $IDXX
August 22, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-great-lakes-advisors-llc-takes-210-million-position-in-idexx-laboratories-inc-idxx-2026-08-22/
Bank of New York Mellon Corp Purchases New Holdings in IDEXX Laboratories, Inc. $IDXX
August 22, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-bank-of-new-york-mellon-corp-purchases-new-holdings-in-idexx-laboratories-inc-idxx-2026-08-22/
Is it a Prudent Move to Retain IDEXX Stock in Your Portfolio Now?
August 21, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2978303/is-it-a-prudent-move-to-retain-idexx-stock-in-your-portfolio-now?cid=cs-stocknewsapi-ft-analyst_blog|rank_focused-2978303
IDXX Raises 2026 EPS Outlook as Diagnostic Growth and Margins Improve
August 20, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2977771/idxx-raises-2026-eps-outlook-as-diagnostic-growth-and-margins-improve?cid=cs-stocknewsapi-ft-analyst_blog_plus|zer_report_insights-2977771
Rationale Behind Baron Focused Growth Fund’s IDEXX Laboratories (IDXX) Holding
August 20, 2026  |  insidermonkey.comhttps://www.insidermonkey.com/blog/rationale-behind-baron-focused-growth-funds-idexx-laboratories-idxx-holding-1821130/
Rationale Behind Baron Focused Growth Fund’s IDEXX Laboratories (IDXX) Holding
August 20, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/rationale-behind-baron-focused-growth-154228414.html
Flossbach Von Storch SE Invests $9.09 Million in IDEXX Laboratories, Inc. $IDXX
August 20, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-flossbach-von-storch-se-invests-909-million-in-idexx-laboratories-inc-idxx-2026-08-20/
Danske Bank A S Buys New Stake in IDEXX Laboratories, Inc. $IDXX
August 20, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-danske-bank-a-s-buys-new-stake-in-idexx-laboratories-inc-idxx-2026-08-20/
Is IDXX Worth Buying as Growth Strength Meets a Premium Valuation?
August 19, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2976926/is-idxx-worth-buying-as-growth-strength-meets-a-premium-valuation?cid=cs-stocknewsapi-ft-analyst_blog_plus|zer_report_insights-2976926
IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors despite daily gains
August 19, 2026  |  marketwatch.comhttps://www.marketwatch.com/data-news/idexx-laboratories-inc-stock-underperforms-tuesday-when-compared-to-competitors-despite-daily-gains-d1e4c3f8-88369e34720a
IDEXX Laboratories, Inc. (IDXX) Analyst/Investor Day Transcript
August 18, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4937492-idexx-laboratories-inc-idxx-analyst-investor-day-transcript
Plato Investment Management Ltd Takes $1.48 Million Position in IDEXX Laboratories, Inc. $IDXX
August 18, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-plato-investment-management-ltd-takes-148-million-position-in-idexx-laboratories-inc-idxx-2026-08-18/
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Receives Consensus Recommendation of "Moderate Buy" from Analysts
August 16, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30963454
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Receives Average Rating of "Moderate Buy" from Analysts
August 16, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/idexx-laboratories-inc-nasdaqidxx-receives-average-rating-of-moderate-buy-from-analysts-2026-08-16/
IDEXX Laboratories Targets $45B Pet Diagnostics Opportunity With AI, Cancer Tests
August 14, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/idexx-laboratories-targets-45b-pet-diagnostics-opportunity-with-ai-cancer-tests-2026-08-14/
IDEXX Laboratories, Inc. (IDXX) Analyst/Investor Day - Slideshow
August 14, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4936889-idexx-laboratories-inc-idxx-analyst-investor-day-slideshow
Handelsbanken Fonder AB Grows Position in IDEXX Laboratories, Inc. $IDXX
August 13, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-handelsbanken-fonder-ab-grows-position-in-idexx-laboratories-inc-idxx-2026-08-13/
Will Strong Q2 2026 Results and New Cardiac Test Change IDEXX Laboratories' (IDXX) Narrative?
August 12, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/strong-q2-2026-results-cardiac-021011441.html
Here's Why Idexx Laboratories (IDXX) is a Strong Growth Stock
August 12, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2973463/here-s-why-idexx-laboratories-idxx-is-a-strong-growth-stock?cid=cs-stocknewsapi-ft-fundamental_analysis|zacks_education_growth_score-2973463

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
AMD logo on a glowing processor chip with red circuit traces, highlighting AI and data-center semiconductor demand.
AMD’s AI Bubble Could Burst Into Explosive Upside
By Thomas Hughes | July 27, 2026
SpaceX logo beside a rocket on a launch pad at sunset, with a colorful sky in the background.
SpaceX’s First Earnings Report Could Decide Whether Shorts or Bulls Have Control
By Jeffrey Neal Johnson | August 3, 2026
Laboratory with a cryogenic quantum processor chamber, optical laser setup on a table, and data monitors displaying waveforms.
Quantum Earnings Week: Winners and Losers Are Finally Emerging
By Nathan Reiff | August 8, 2026
SoundHound AI logo displayed within a glowing orange ring against a dark background with light wave effects.
SoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat
By Thomas Hughes | August 10, 2026
GE HealthCare logo displayed on a wall beside an MRI scanner in a futuristic imaging suite.
GE HealthCare Stock Climbs on Vital Diagnostics Demand
By Jeffrey Neal Johnson | August 1, 2026
DexCom stock logo

DexCom NASDAQ:DXCM

$89.16 -1.90 (-2.09%)
Closing price 08/25/2026 04:00 PM Eastern
Extended Trading
$89.17 +0.01 (+0.01%)
As of 04:03 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

GE HealthCare Technologies stock logo

GE HealthCare Technologies NASDAQ:GEHC

$73.91 -0.28 (-0.38%)
Closing price 08/25/2026 04:00 PM Eastern
Extended Trading
$74.18 +0.27 (+0.36%)
As of 04:13 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The Ultrasound segment provides medical devices and solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring solutions, anesthesia delivery and respiratory care products, electrocardiogram solutions, maternal infant care products, and consumables and services. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. It has an AI collaboration with Mass General Brigham. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.

Globus Medical stock logo

Globus Medical NYSE:GMED

$83.13 -0.95 (-1.13%)
Closing price 08/25/2026 03:59 PM Eastern
Extended Trading
$83.69 +0.56 (+0.67%)
As of 04:11 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

IDEXX Laboratories stock logo

IDEXX Laboratories NASDAQ:IDXX

$550.01 -9.50 (-1.70%)
Closing price 08/25/2026 04:00 PM Eastern
Extended Trading
$554.72 +4.71 (+0.86%)
As of 04:02 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas